![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1297828
¼¼°èÀÇ ¼Òȱ⠳»½Ã°æ¿ë °¡À̵å¿ÍÀÌ¾î ½ÃÀå(2023-2030³â)Global GI Endoscopy Guidewire Market - 2023-2030 |
¼Òȱ⠳»½Ã°æ¿ë °¡À̵å¿ÍÀÌ¾î ¼¼°è ½ÃÀåÀº 2022³â 2¾ï 5,750¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2030³â¿¡´Â 3¾ï 4,990¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼Òȱ⠳»½Ã°æ¿ë °¡À̵å¿ÍÀÌ¾î ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2023-2030³â) µ¿¾È 4.5%ÀÇ CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
°¡À̵å¿ÍÀ̾î´Â ´Ù¾çÇÑ ±æÀÌ¿Í Á÷°æÀ¸·Î Á¦°øµÇ¸ç Á¾Á¾ ½ºÅ×Àη¹½º ½ºÆ¿ ¶Ç´Â ÀÌ¿Í µ¿µîÇÑ Àç·á·Î ±¸¼ºµË´Ï´Ù. ³»½Ã°æÀÇ ºÎ¼Ó ä³Î ¶Ç´Â ÀÛ¾÷ ä³ÎÀ» ÅëÇØ »ðÀÔµÇ¾î ³»½Ã°æ Àǻ簡 °¡À̵å¿ÍÀ̾ ¼ÒȰü ³» ¸ñÇ¥ ºÎÀ§·Î ÁøÇàÇÒ ¼ö ÀÖ½À´Ï´Ù.
ƯÈ÷ ´ëÀå¾Ï °ËÁøÀ²ÀÇ Áõ°¡´Â ¼Òȱâ ÁúȯÀÇ Á¶±â ¹ß°ß°ú °ËÁøÀÇ °¡Ä¡¿¡ ´ëÇÑ ´ëÁßÀÇ ÀνÄÀÌ ³ô¾ÆÁø °á°úÀÔ´Ï´Ù. °¡À̵å¿ÍÀ̾îÀÇ »ç¿ëÀº ´ëÀå ³»½Ã°æ °Ë»ç¿Í °°Àº ¼±º° °Ë»ç¿¡¼ ÀÚÁÖ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¼ú¿¡¼ °¡À̵å¿ÍÀ̾îÀÇ Çʿ伺Àº °ËÁøÀ²ÀÌ ³ô¾ÆÁü¿¡ µû¶ó Áõ°¡ÇÕ´Ï´Ù.
¼Òȱ⠳»½Ã°æ °Ë»ç¿¡¼ ÀÌ»óÀÌ ¹ß°ßµÇ¸é °æ¿ì¿¡ µû¶ó Ä¡·áÀû Á¶Ä¡°¡ ÇÊ¿äÇÒ ¼öµµ ÀÖ½À´Ï´Ù. »ý°Ë °âÀÚ, ¿ëÁ¾ ÀýÁ¦¿ë ¿Ã°¡¹Ì, ÇùÂø ¹× ÇùÂø¿ë ½ºÅÙÆ® µîÀÇ Ä¡·á µµ±¸´Â ¸ðµÎ °¡À̵å¿ÍÀ̾î·Î À¯µµ ÇÒ ¼ö ÀÖ½À´Ï´Ù. Ä¡·áÀû °³ÀÔ¿¡ ´ëÇÑ ¼ö¿ä¿Í °¡À̵å¿ÍÀ̾îÀÇ »ç¿ëÀº ¸ðµÎ °ËÁøÀ²ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Áõ°¡ÇÕ´Ï´Ù.
¼Òȱ⠳»½Ã°æ¿ë °¡À̵å¿ÍÀ̾îÀÇ »ç¿ë Áõ°¡´Â ´ëÀå¾Ï°ú °°Àº ¼Òȱâ ÁúȯÀ» ´ë»óÀ¸·Î ÇÑ È°µ¿ÀÇ °á°úÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÇÁ·Î±×·¥¿¡´Â °ËÁø Ä·ÆäÀÎ, °øÁߺ¸°Ç Ä·ÆäÀÎ, ÀÌÇØ°ü°èÀÚ ¹× ÀÇ·á ¼ºñ½º Á¦°øÀÚ¿ÍÀÇ ÆÄÆ®³Ê½Ê µîÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ Ä·ÆäÀÎÀº ÀÎÁöµµ¸¦ ³ôÀ̰í Á¶±â ¹ß°ßÀ» Àå·ÁÇÔÀ¸·Î½á ´õ ¸¹Àº »ç¶÷µéÀÌ ¼Òȱ⠳»½Ã°æ °Ë»ç¸¦ ¹Þµµ·Ï Àå·ÁÇϰí ÀÖÀ¸¸ç, ¿©±â¿¡´Â °¡À̵å¿ÍÀ̾ ÇÊ¿äÇÑ °æ¿ìµµ Æ÷ÇԵ˴ϴÙ. ³»½Ã°æÀº ¾î·Á¿î ÁúȯÀ» Ä¡·áÇÏ´Â µ¿¾È °¡À̵å¿ÍÀ̾ ÅëÇØ À¯µµµÇ¾î Á¤È®ÇÑ ½Ã°¢È¿Í È®½ÇÇÑ Áø´ÜÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¼Òȱ⠳»½Ã°æ °¡À̵å¿ÍÀ̾ ´ëÇÑ ¼ö¿ä´Â ÁýÁßÀûÀÎ ³ë·ÂÀÌ È®»êµÊ¿¡ µû¶ó Áõ°¡ÇÏ¿© ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ°í ¼Òȱâ ÁúȯÀÇ Á¶±â Ä¡·á¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
COVID-19ÀÇ À¯ÇàÀº ¼Òȱ⠳»½Ã°æ °¡À̵å¿ÍÀÌ¾î ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÃÆÀ¸¸ç, COVID-19ÀÇ ´ëÀ¯ÇàÀ¸·Î ÀÎÇØ ÀÇ·á ½Ã¼³ÀÇ ¾ÈÀü°ú °¨¿° ÅëÁ¦¿¡ ´ëÇÑ ¿ì·Á°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ³»½Ã°æ ½Ã¼³°ú º´¿øÀº °³Àκ¸È£±¸(PPE) »ç¿ë Áõ°¡, ¼¼Ã´ ÀýÂ÷ °³¼±, ȯÀÚ È帧 ÀýÂ÷ º¯°æ µî º¸´Ù ¾ö°ÝÇÑ Á¶Ä¡¸¦ ÃëÇß½À´Ï´Ù. ÀÌ·¯ÇÑ Á¶Ä¡´Â ÀÇ·á ½Ã¼³ÀÇ ºñ¿ë°ú ¹°·ù ¹®Á¦¸¦ Áõ°¡½ÃÄÑ °¡À̵å¿ÍÀ̾îÀÇ ¼ö¿ë°ú »ç¿ë¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.
·¯½Ã¾Æ-¿ìÅ©¶óÀ̳ª ºÐÀïÀÌ ¼Òȱ⠳»½Ã°æ °¡À̵å¿ÍÀÌ¾î ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀº º¹ÀâÇÏ°í ´Ù¸éÀûÀÔ´Ï´Ù. Æø·Â »çÅ·ΠÀÎÇØ ÇÇÇØ Áö¿ª¿¡¼´Â ÀÇ·á ½Ã½ºÅÛÀÌ Å©°Ô È¥¶õ½º·¯¿öÁ³½À´Ï´Ù. º´¿ø ¹× ±âŸ ÀÇ·á ±â°ü¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ ¼Õ»óµÇ¾î ³»½Ã°æ Ä¡·á ¹× °¡À̵å¿ÍÀ̾î¿Í °°Àº °ü·Ã ÀåºñÀÇ È¹µæ¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.
The Global GI Endoscopy Guidewire Market reached US$ 257.5 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 349.9 million by 2030. The Global GI Endoscopy Guidewire Market is expected to exhibit a CAGR of 4.5% during the forecast period (2023-2030).
The guidewire comes in a variety of lengths and diameters and is often composed of stainless steel or comparable material. It is inserted through an accessory channel or working channel of the endoscope, allowing the endoscopist to advance it into the targeted area within the GI tract.
Increased screening rates, particularly for colorectal cancer, are the result of growing public awareness of the value of early identification and screening for GI diseases. The use of guidewires is frequently necessary during screening procedures like colonoscopies, which are advised for those over a certain age or who have a certain set of risk factors. The need for guidewires in these operations rises as screening rates do.
Therapeutic measures may be necessary in some instances if GI endoscopic tests reveal abnormalities. Therapeutic tools like biopsy forceps, snares for removing polyps, or stents for narrowing or strictures can all be guided by guidewires. The demand for therapeutic interventions and the use of guidewires both rise with higher screening rates.
The rising use of GI endoscopy guidewires is a result of targeted activities for GI disorders such as colorectal cancer. These programs include screening campaigns, public health campaigns, and stakeholder and healthcare provider partnerships. These campaigns encourage more people to have GI endoscopy procedures, including those requiring guidewires, by increasing awareness and encouraging early detection. Endoscopes are guided by guidewires during therapeutic treatments in difficult cases, enabling precise visualization and reliable diagnosis. The need for GI endoscopic guidewires is anticipated to increase as focused initiatives spread, promoting better patient outcomes and the early treatment of GI disorders.
The COVID-19 pandemic has had a significant impact on the GI Endoscopy Guidewire market. The COVID-19 pandemic increased worries about safety and infection control in healthcare facilities. Stricter measures were put in place by endoscopy facilities and hospitals, including increased use of personal protective equipment (PPE), improved cleaning procedures, and altered patient flow procedures. Although required, these actions increased expenses and logistical difficulties for healthcare facilities, which can have an impact on guidewire acceptance and use.
The impact of the Russia-Ukraine war on the GI endoscopy guidewire market is complex and multifaceted. In the impacted areas, the violence has severely disrupted the healthcare system. The accessibility of hospitals and other medical institutions may have been compromised, affecting the availability of endoscopic treatments and associated equipment, such as guidewires.
The global GI endoscopy guidewire market is segmented based on material, indication, design, end-user, and region.
The colonoscopy segment accounted for the highest market stake accounting for approximately 39.6% of the GI endoscopy guidewire market in 2022. The large intestine (colon) is examined using a colonoscopy, a frequent diagnostic and therapeutic technique, to look for anomalies including polyps, tumors, or inflammation. Although they are not frequently utilized in colonoscopies, guidewires may be used in some circumstances. A guidewire may occasionally be used during a colonoscopy to help the endoscope pass through difficult anatomical variations, strictures, or convoluted sections of the colon. The endoscope can be guided and advanced through the colon with the aid of the guidewire.
Europe is expected to dominate the GI endoscopy guidewire market, accounting for around 26.8% of this market. The market players are offering the products in the region to strengthen their business in the European region. For instance, the Barr 360 express RFA balloon catheter, Barr 360 RFA balloon catheter, and the Barr 360 soft-sizing balloon can all be exchanged with the use of Barr RFA endoscopic guidewires.
The major global players in the market include: Boston Scientific Corporation, CONMED Corporation, COOK MEDICAL Inc, HOBBS MEDICAL INC, Olympus Corporation, Medico's-Hirata Inc, Sumitomo Bakelite Co., Ltd, Diagmed Healthcare, Omnimed Ltd, and Merit medical systems among others.
The global GI endoscopy guidewire market report would provide approximately 68 tables, 69 figures, and 195 pages.
LIST NOT EXHAUSTIVE